Analyst Ratings for Genomic Health Inc. (GHDX)Updated: 2017-07-28
Genomic Health Inc. (NASDAQ:GHDX) was awarded an average rating of Hold from investment analysts following the stock. A consensus rating of Hold was previously issued for GHDX last month.
3 analysts declared GHDX a buy, 0 issued an overweight rating, 8 issued a hold rating, 1 gave an underweight rating, and 1 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has decreased by 1. During this time, the number of analysts bearish on the stock has increased by 0.
A number of analysts gave price targets for GHDX. The most optimistic price target was 40, which equates to a potential upside of 23.65 percent. The minimum price target given was 27, implying a possible loss of -16.54 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.
Analysts have revised their earnings estimates upwards for this quarter, by about 0 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is -200 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of -25 percent in FY estimates.
Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, which can be compared to the 0 analysts that decreased their estimates. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.
In the last 52-weeks, GHDX has achieved a high of 33.97 and a low of 25.66. The current market price is above the trailing year's low by 26.07 percent, and below the high by 4.77 percent. GHDX has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The GHDX value stock report compares GHDX to some of its peers using value stock charts. The stock has a market capitalization of $1.1 billion. GHDX's next earnings release will be on 0000-00-00, which is days away.